7028 Dasatinib and docetaxel combination treatment for patients with metastatic castration-resistant prostate cancer (CRPC): analysis of Study CA180–086 by Araujo, J, Mathew, P, Armstrong, A.J, Braud, E.L, Posadas, E, Lonberg, M, Gallick, G, Trudel, G.C, Paliwal, P, Logothetis, C.J

Get full text